This inventor holds 3 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Endomedix, Inc.. Active years: 2019-2024.
Company Filing History:
Years Active: 2019-2024
Title: Richard Russo: Innovator in Hemostasis Technology
Introduction
Richard Russo is a notable inventor based in Morristown, NJ (US). He has made significant contributions to the field of medical technology, particularly in the area of hemostasis. With a total of 3 patents to his name, Russo's work focuses on innovative solutions for blood clot formation and surgical applications.
Latest Patents
One of Russo's latest patents is centered around methods and compositions for achieving hemostasis and stable blood clot formation. This invention involves a tunable biopolymer hydrogel produced from two processed natural polysaccharides. The hydrogel is designed for use as a hemostat, capable of forming within seconds when applied to a tissue lesion. The resulting hydrogel adheres to tissue and produces hemostasis without swelling, which is crucial during surgical procedures. This technology is particularly beneficial in surgeries involving the brain or spine, where swelling could pose significant risks.
Career Highlights
Richard Russo has established himself as a key figure in the medical technology sector. His work at Endomedix, Inc. has allowed him to develop groundbreaking solutions that address critical challenges in surgical procedures. His innovative approach to hemostasis has the potential to save lives and improve surgical outcomes.
Collaborations
Throughout his career, Russo has collaborated with talented professionals in the field, including Piyush Modak and Malavika Nadig. These collaborations have further enhanced the development and application of his innovative technologies.
Conclusion
Richard Russo's contributions to hemostasis technology exemplify the impact of innovation in the medical field. His patents and work at Endomedix, Inc. highlight the importance of developing effective solutions for surgical challenges.
